Sec Form 4 Filing - Salameh Roger @ Arcadia Biosciences, Inc. - 2016-08-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Salameh Roger 2. Issuer Name and Ticker or Trading Symbol Arcadia Biosciences, Inc. [ RKDA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Operating Officer (Last) (First) (Middle) C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105 3. Date of Earliest Transaction (MM/DD/YY) 08/04/2016 (Street) DAVIS, CA95618 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/04/2016 M 100 A $ 1.08 11,515 D Common Stock 08/04/2016 S( 1 ) 100 D $ 2.51 11,415 ( 2 ) D Common Stock 1,297 ( 3 ) I By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (right to buy) $ 1.08 08/04/2016 M 100 ( 4 ) 06/30/2018 Common Stock 100 $ 0 72,400 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Salameh Roger C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS, CA95618 Chief Operating Officer Signatures Roger Salameh, by Attorney-in-Fact, Wendy S. Neal 08/08/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 14, 2016. ( 2 )The total securities reflects the transfer of all rights and ownership interest in and to 9,006 shares (or 50% of the total beneficially owned) to the Reporting Person's ex-wife effective December 10, 2015, and the acquisition of 750 shares and 1,659 shares on February 1 and August 1, 2016, respectively, through participation in the Issuer's 2015 Employee Stock Purchase Plan. ( 3 )Represents the acquisition of 667 and 630 shares on February 1 and August 1, 2016, respectively, by the Reporting Person's spouse through her participation in the Issuer's 2015 Employee Stock Purchase Plan, for which the Reporting Person disclaims beneficial ownership. ( 4 )The option is fully exercisable as of the date hereof.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.